Theranostics for Neuroendocrine Tumors: Glenda Journey
Meet Glenda
After receiving the diagnosis of neuroendocrine tumors, Glenda’s oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred to NCS for theranostics treatment.
Read more about Glenda’s story!
